- Home
- CTSO vs RAVE Comparison
CTSO vs RAVE Comparison
Compare CTSO & RAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- RAVE
- Stock Information
- Founded
- CTSO 1997
- RAVE 1958
- Country
- CTSO United States
- RAVE United States
- Employees
- CTSO N/A
- RAVE N/A
- Industry
- CTSO Medical/Dental Instruments
- RAVE Restaurants
- Sector
- CTSO Health Care
- RAVE Consumer Discretionary
- Exchange
- CTSO Nasdaq
- RAVE Nasdaq
- Market Cap
- CTSO 58.6M
- RAVE 49.0M
- IPO Year
- CTSO N/A
- RAVE N/A
- Fundamental
- Price
- CTSO $0.92
- RAVE $2.89
- Analyst Decision
- CTSO Buy
- RAVE
- Analyst Count
- CTSO 2
- RAVE 0
- Target Price
- CTSO $5.50
- RAVE N/A
- AVG Volume (30 Days)
- CTSO 78.2K
- RAVE 47.7K
- Earning Date
- CTSO 11-06-2025
- RAVE 11-06-2025
- Dividend Yield
- CTSO N/A
- RAVE N/A
- EPS Growth
- CTSO N/A
- RAVE 9.62
- EPS
- CTSO N/A
- RAVE 0.19
- Revenue
- CTSO $36,107,520.00
- RAVE $12,039,000.00
- Revenue This Year
- CTSO $11.93
- RAVE N/A
- Revenue Next Year
- CTSO $21.22
- RAVE N/A
- P/E Ratio
- CTSO N/A
- RAVE $14.86
- Revenue Growth
- CTSO 20.18
- RAVE N/A
- 52 Week Low
- CTSO $0.71
- RAVE $2.01
- 52 Week High
- CTSO $1.61
- RAVE $3.75
- Technical
- Relative Strength Index (RSI)
- CTSO 45.35
- RAVE 35.78
- Support Level
- CTSO $0.90
- RAVE $2.73
- Resistance Level
- CTSO $0.96
- RAVE $3.37
- Average True Range (ATR)
- CTSO 0.05
- RAVE 0.27
- MACD
- CTSO -0.00
- RAVE -0.07
- Stochastic Oscillator
- CTSO 16.67
- RAVE 18.14
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About RAVE Rave Restaurant Group Inc.
Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens. It operates restaurants under the brand name, Pizza Inn, and Pie Five Pizza Company. It has three operating segments. The Pizza Inn and Pie Five Franchising segments establish franchisees, licensees, and territorial rights. The company-owned restaurant segment includes sales and operating results for all company-owned restaurants. The Pizza Inn Franchising segment accounts for the company's revenue. Geographically, it generates the majority of the revenue from the United States.